Trial Profile
Comparison of sugammadex and pyridostigmine for reversal of neuromuscular blockade in the absence of neuromuscular monitoring in patients undergoing laryngeal microsurgery: A single-centered retrospective study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Sep 2015
Price :
$35
*
At a glance
- Drugs Sugammadex (Primary) ; Pyridostigmine
- Indications Neuromuscular blockade
- Focus Therapeutic Use
- 23 Sep 2015 Status changed from recruiting to completed, according to University Hospital Medical Information Network - Japan record.
- 26 Feb 2015 New trial record